|
covid-19 |
16 |
|
vaccine |
13 |
|
adolescents |
12 |
|
children |
12 |
|
convalescence |
12 |
|
sars-cov-2 |
12 |
|
sars-cov-2 rbd igg |
12 |
|
t cell response |
12 |
|
coronavac |
10 |
|
immunotherapy |
9 |
|
adolescent |
7 |
|
omicron |
7 |
|
bnt162b2 |
6 |
|
coronavirus disease 2019 |
6 |
|
exosomes |
6 |
|
extracellular vesicle |
6 |
|
head and neck neoplasms |
6 |
|
immunity |
6 |
|
immunogenicity |
6 |
|
intradermal |
6 |
|
neuromuscular diseases |
6 |
|
radiotherapy |
6 |
|
t-lymphocytes |
6 |
|
tumor |
6 |
|
tumor microenvironment |
6 |
|
γδ-t cells |
6 |
|
ampk |
5 |
|
glucose metabolism |
5 |
|
lactate |
5 |
|
t2dm |
5 |
|
tumor surveillance |
5 |
|
γδ t cells |
5 |
|
cancer immunotherapy |
4 |
|
hybrid exosomes |
4 |
|
photoimmunotherapy |
4 |
|
photosensitive nanoparticles |
4 |
|
γδ-t exosomes |
4 |
|
adaptive immunity |
3 |
|
animal cell |
3 |
|
animal experiment |
3 |
|
animal model |
3 |
|
animal tissue |
3 |
|
antitumor acitivity |
3 |
|
cd137 |
3 |
|
extracellular vesicles |
3 |
|
il-10 |
3 |
|
interleukin-17-producing γδ-t cells |
3 |
|
microrna-15a |
3 |
|
nasopharyngeal carcinoma |
3 |
|
pkh67 |
3 |
|
radioresistance |
3 |
